24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publication dates

Chemotherapy Industry, January 2015 Market Reports from Top Publishers

You might be interested in: flow cytometry, hematology, cancer, therapeutics, colorectal cancer, medical equipment, breast cancer, cancer drug, drug, cancer therapeutics, peripheral neuropathy, prostate cancer, radiation therapy, diarrhea, alopecia.


 
1-10 of 82 reports for Chemotherapy

Quest PharmaTech Inc. (Symbol:QPT) SWOT Analysis, Strategy, Revenues and Profits

Quest PharmaTech Inc. (Symbol:QPT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... For the treatment of cancer by combining immunotherapeutic antibodies with chemotherapy, photodynamic therapy, or immunoadjuvants. Its technology platform includes a series of monoclonal antibodies that target ...

TOWA PHARMACEUTICAL CO., LTD. (Symbol:4553) SWOT Analysis, Strategy, Revenues and Profits

TOWA PHARMACEUTICAL CO., LTD. (Symbol:4553) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Allergy, bacterial infections, chemotherapy, metabolism, cardiology and respiratory. The company operates through research laboratories, manufacturing and distribution centers in osaka, okayama and yamagata ...

Cleveland BioLabs, Inc. (Symbol:CBLI) SWOT Analysis, Strategy, Revenues and Profits

Cleveland BioLabs, Inc. (Symbol:CBLI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... And commercializes drugs to treat cancer and orphan indications and protect healthy tissues from radiation and chemotherapy. Its products include entolimod biodefense, entolimod oncology, cbl0137, cbl0102, cblb612 ...

KPJ Healthcare Berhad (Symbol:KPJ) SWOT Analysis, Strategy, Revenues and Profits

KPJ Healthcare Berhad (Symbol:KPJ) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Pathology, occupational health services, orthopaedic and trauma surgery, ophthalmic laser, colorectal surgery, ophthalmic surgery, cancer and chemotherapy services, orthodontic and maxillafacial surgery ...

PledPharma AB (PLED) - Financial and Strategic SWOT Analysis Review

PledPharma AB (PLED) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... For conditions related to oxidative stress during treatment of life threatening diseases. It also provides pledox, used to prevent chemotherapy-induced side effects for colorectal cancer. Pled ...

Tesaro, Inc. (TSRO) - Financial and Strategic SWOT Analysis Review

Tesaro, Inc. (TSRO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Licensing, developing and commercializing oncology therapeutics and supportive care products. The pipeline portfolio of the company includes rolapitant (oral) for chemotherapy-induced nausea and vomiting (cinv) is under ...

Global Acute Myeloid Leukemia Therapeutics Market 2015-2019

Global Acute Myeloid Leukemia Therapeutics Market 2015-2019

  • $ 2 500
  • Industry report
  • December 2014
  • by Infiniti Research Limited

... To radiations, cancer patients, who are treated with chemotherapy, blood disorder or genetic mutations are some of the risk factors for the development of acute myeloid leukemia in patients ...

Respiratory Therapy News DECEMBER 2014

Respiratory Therapy News DECEMBER 2014

  • $ 1 114
  • Industry report
  • December 2014
  • by Espicom Business Intelligence

... For nsclc after first-line chemotherapyindustry brief - teva launches erlotinib in canadaindustry brief - dosing begins in oncomed's tarextumab phase ii trial for sclcindustry brief - dynavax ...

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2014

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

... Therapeutic landscape of chemotherapy induced peripheral neuropathy- the report reviews key pipeline products under drug profile section which includes, product description, moa and r&d brief, licensing ...

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014

Chemotherapy Induced Neutropenia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

... Pipeline projects- coverage of the chemotherapy induced neutropenia pipeline on the basis of target, moa, route of administration and molecule type- latest news and deals relating related to pipeline ...

About 2 600 reports for Chemotherapy

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • January 2014
    72 pages
  • Cancer  

  • United States  

    North America  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.